Eli Lilly, J&J and AbbVie Hit Record Highs as Healthcare Outperforms S&P 500
Updated
Updated · Seeking Alpha · Jun 26
Eli Lilly, J&J and AbbVie Hit Record Highs as Healthcare Outperforms S&P 500
3 articles · Updated · Seeking Alpha · Jun 26
Summary
Eli Lilly, Johnson & Johnson and AbbVie all climbed to all-time highs on Friday, making healthcare one of Wall Street’s strongest-performing sectors.
Those gains stood out because healthcare stocks had lagged the broader market year to date before Friday’s rally lifted several of the sector’s biggest S&P 500 components.
The move signals renewed investor demand for large-cap defensive healthcare names even after a period of relative underperformance.